Sales Of Pegfilgrastim Biosimilar To Exhibit 10% CAGR Through 2026 | Fact.MR Study
Chemotherapy and/or radiotherapy is used for the treatment of most cancers. However, chemotherapy and radiotherapy have a very common side effect called neutropenia, and pegfilgrastim is required [read full press release…]